India · Delayed Price · Currency is INR Zydus Lifesciences Statistics
Total Valuation
BOM:532321 has a market cap or net worth of INR 910.34 billion. The enterprise value is 963.89 billion.
| Market Cap | 910.34B |
| Enterprise Value | 963.89B |
Important Dates
The last earnings date was Monday, February 9, 2026.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | Jul 25, 2025 |
Share Statistics
| Current Share Class | 1.01B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 75.03% |
| Owned by Institutions (%) | 14.32% |
| Float | 249.56M |
Valuation Ratios
The trailing PE ratio is 18.43 and the forward PE ratio is 21.27.
| PE Ratio | 18.43 |
| Forward PE | 21.27 |
| PS Ratio | 3.49 |
| PB Ratio | 3.24 |
| P/TBV Ratio | 9.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.52 |
| EV / Sales | 3.69 |
| EV / EBITDA | 13.05 |
| EV / EBIT | 15.09 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.32 |
| Debt / FCF | n/a |
| Interest Coverage | 19.66 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.34% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.35M |
| Profits Per Employee | 1.77M |
| Employee Count | 27,917 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532321 has paid 17.00 billion in taxes.
| Income Tax | 17.00B |
| Effective Tax Rate | 25.27% |
Stock Price Statistics
The stock price has decreased by -3.14% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -3.14% |
| 50-Day Moving Average | 905.70 |
| 200-Day Moving Average | 951.71 |
| Relative Strength Index (RSI) | 51.41 |
| Average Volume (20 Days) | 33,046 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532321 had revenue of INR 260.89 billion and earned 49.38 billion in profits. Earnings per share was 49.07.
| Revenue | 260.89B |
| Gross Profit | 188.76B |
| Operating Income | 62.93B |
| Pretax Income | 67.26B |
| Net Income | 49.38B |
| EBITDA | 72.78B |
| EBIT | 62.93B |
| Earnings Per Share (EPS) | 49.07 |
Balance Sheet
The company has 70.69 billion in cash and 96.36 billion in debt, with a net cash position of -25.68 billion.
| Cash & Cash Equivalents | 70.69B |
| Total Debt | 96.36B |
| Net Cash | -25.68B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 280.90B |
| Book Value Per Share | 251.49 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 72.35%, with operating and profit margins of 24.12% and 18.93%.
| Gross Margin | 72.35% |
| Operating Margin | 24.12% |
| Pretax Margin | 25.78% |
| Profit Margin | 18.93% |
| EBITDA Margin | 27.89% |
| EBIT Margin | 24.12% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.24%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 1.24% |
| Dividend Growth (YoY) | 266.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 1.35% |
| Earnings Yield | 5.42% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |